SHFH (Scientist Home Future Health) EBIT: $-0.40 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHFH Scientist Home Future Health Ltd SHFH
8 GF Score
Price $5.00
! 2 Warning Signs
View Full Analysis

What is Scientist Home Future Health EBIT?

Scientist Home Future Health SHFH +11.11% 8 EBIT is $-0.40 Mil as of Jun. 2026. GuruFocus rates SHFH with a GF Score™ of 8/100. The stock has 2 warning signs investors should review.

Scientist Home Future Health's earnings before interest and taxes (EBIT) for the three months ended in Jun. 2026 was $-0.10 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Jun. 2026 was $-0.40 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Scientist Home Future Health's annualized ROC % for the quarter that ended in Jun. 2026 was -77.70%. Scientist Home Future Health's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jun. 2026 was -94.23%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Scientist Home Future Health's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jun. 2026 was -0.34%.


Scientist Home Future Health  (OTCPK:SHFH) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Scientist Home Future Health's annualized ROC % for the quarter that ended in Jun. 2026 is calculated as:

ROC % (Q: Jun. 2026 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Mar. 2026 ) + Invested Capital (Q: Jun. 2026 ))/ count )
=-0.392 * ( 1 - 0% )/( (0.501 + 0.508)/ 2 )
=-0.392/0.5045
=-77.70 %

where

Note: The Operating Income data used here is four times the quarterly (Jun. 2026) data.

2. Joel Greenblatt's definition of Return on Capital:

Scientist Home Future Health's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jun. 2026 is calculated as:

ROC (Joel Greenblatt) %(Q: Jun. 2026 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Mar. 2026  Q: Jun. 2026
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-0.392/( ( (0.427 + max(-0.06, 0)) + (0.405 + max(-0.121, 0)) )/ 2 )
=-0.392/( ( 0.427 + 0.405 )/ 2 )
=-0.392/0.416
=-94.23 %

where Working Capital is:

Working Capital(Q: Mar. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0 + 0.031 + 0.086) - (0.178 + 0 + -0.001)
=-0.06

Working Capital(Q: Jun. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0 + 0.034 + 0.082) - (0.237 + 0 + 5.5511151231258E-17)
=-0.121

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Jun. 2026) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Scientist Home Future Health's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Jun. 2026 )
=-0.401/118.950
=-0.34 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Scientist Home Future Health EBIT Related Terms


Scientist Home Future Health EBIT Historical Data

* Premium members only.

The historical data trend for Scientist Home Future Health's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Scientist Home Future Health EBIT Chart

Scientist Home Future Health Annual Data
Trend Dec24 Dec25
EBIT
0.00 -0.23

Scientist Home Future Health Quarterly Data
Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
EBIT Get a 7-Day Free Trial -0.04 -0.05 -0.15 -0.10 -0.10

SHFH vs BHIC, PETS, SCNX: EBIT Comparison

For the Pharmaceutical Retailers subindustry, Scientist Home Future Health's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Scientist Home Future Health EV-to-EBIT vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Scientist Home Future Health's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Scientist Home Future Health's EV-to-EBIT falls into.


SHFH
8GF Score
Scientist Home Future Health Ltd SHFH
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Scientist Home Future Health EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.40 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of $-0.40 Mil mean?
Scientist Home Future Health (SHFH) has a EBIT of $-0.40 Mil as of Jun. 2026. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Scientist Home Future Health.
Is Scientist Home Future Health's EBIT too high?
Scientist Home Future Health's current EBIT is $-0.40 Mil. Overall, Scientist Home Future Health has a GF Score™ of 8/100, reflecting its overall financial health beyond just this single metric.
How does Scientist Home Future Health's EBIT compare to BHIC and PETS?
Scientist Home Future Health's EBIT of $-0.40 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Healthcare Providers & Services company?
A good EBIT depends on the Healthcare Providers & Services industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Scientist Home Future Health. Scientist Home Future Health's current EBIT is $-0.40 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Scientist Home Future Health stock overvalued right now?
Scientist Home Future Health (SHFH) has a current EBIT of $-0.40 Mil. The current EBIT is $-0.40 Mil. Scientist Home Future Health's overall GF Score™ is 8/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Scientist Home Future Health (SHFH), the current EBIT is $-0.40 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Scientist Home Future Health Business Description

Address 205 Wai Yip Street, Room B3, Block B, 3rd Floor, Mow Hing Industrial Building, Kwun Tong, Kowloon, HKG
Scientist Home Future Health Ltd, through its subsidiaries, engages in the retail trading of health supplements and topical creams and provision of physical check-up services in Hong Kong. It focuses on developing sustainable rehabilitation solutions, particularly for degenerative diseases, ensuring that the products not only address current symptoms but also support future, long-term health and recovery. The company has two reportable segments based on business unit, retail trading and service business. The majority of revenue is derived from the Retail Trading segment, which derives revenue from customers by providing health supplements and topical creams. It has two reportable segments based on geographical location: Hong Kong and Non-Hong Kong; key revenue derives from Hong Kong.
8GF Score

Get the complete analysis for SHFH

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$5.00
Price